Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
L2's anyone please?
Nice upticking now !!!!
Yes, people are gonna be very very sad when MMs quit playing games and those that have dumped right now....
All we need is a PR and BOOM! Stock will go up.
This is a great company.
Why the lull this morning in CGOC?
Is there a contact for the company?
Can someone call and ask about PR? or other facts as to the volume?
L2s Please... Thanks!
Let's go GCOG !!!
Is a PR expected?
I heard the company puts out like around 10am...
Anyone talk to the company?
Yes, Breakout !!!
The last breakout took us to .002......
Awesome!!
Press Release Source: INTER CANADIAN BUSINESS SERVICE
ICBS acquires 30% interest in Bacteria Bank Ltd.
Tuesday October 30, 10:48 am ET
NEW YORK and MONTREAL, Oct. 30 /PRNewswire-FirstCall/ - ICBS Limited (PINKSHEETS: ICBM - News), today announced the acquisition of 30% interest in Bacteria Bank Ltd.
Bacteria Bank Ltd., is a Bio medical company that owns over ten thousand cryogenically stored bacteria for use in medical research, located in Montreal Canada. The company is headed by Dr. Karl Weiss a world renowned bacteriologist.
Dr. Karl Weiss is a Microbiologist and Infectious Diseases Specialist at Maisonneuve-Rosemont Hospital in Montreal . He is also Associate Clinical Professor at the Faculty of Medicine at University of Montreal , and the director of pharmacological research at Maisonneuve-Rosemont hospital. He is also an associate member of the division of infectious diseases at the Jewish General Hospital in Montreal , and an adjunct-professor of Medicine at McGill University.
Bacteria bank has a unique collection of over 10,000 frozen bacteria which can be used for many different purposes.
1. susceptibility testing of potentially promising anti-microbial
agents developed by biotech companies or researchers in
universities.
2. susceptibility testing of new antibiotics against specific and
emerging pathogens such as MRSA ( Methicillin resistant
Staphyloccocus aureus), VRE ( Vancomycin Resistant Enterococcus).
3. susceptibility testing against a wide array of Gram negative
agents ( E. coli, Salmonella, shigella, and other gastro-
intestinal pathogens responsible for million of deaths every year
in the world)
4. susceptibility testing of new agents against Streptococcus
pneumoniae responsible for the majority of sinusitis, otitis
media, pneumonia and some forms of bronchitis. In North America
only, there are over 300 million of antibiotic prescriptions in
the outpatients setting, and S.pneumonie is the number one target
overall by far.
5. bacteria useful for the development of newly designed genetically
derived products ( human and animal hormones, growth factors,
cytokines...)
6. bacteria useful for teaching purposes ( Pharmaceutical companies,
universities and medical schools)
Speaking from the corporate head office in Montreal, Garth McIntosh, President &CEO of ICBS said, " This acquisition will further strengthen our position in the Bio medical industry". ICBS also owns 100% of Canadian Bio Med Systems Ltd. McIntosh further stated " I want to thank all of our shareholders that have supported us in the past year, we are working very hard to make this a profitable year for all. Thank you all for your encouragement and support".
You can visit them at: www.bacteriabank.com
This news release includes statements that constitute forward-looking statements. Please be aware that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may vary materially from those in the forward-looking statements as a result of any number of factors, including the risk factors contained in the Company's disclosure documents.
--------------------------------------------------------------------------------
Source: INTER CANADIAN BUSINESS SERVICE
ICBM gonna gap up today I hope..... Let's hope for .0015 !!!
Where will we go today? .0015 ?
Please forgive my newbie ignorance, but being that O/S and A/S are the same, this is really good right?
That means this is gonna fly big time?
Where do you think we will go to Monday?
.0015 ? .002 ?
Is this good?
I don't know just yet... haha
I thought we would close at .0015.
I think we will run really good on Monday.
What do others think?
If stocks like ICBM and GCOG trade after hours?
1.) How do I set up my account to trade after hours? Does this cost money?
2.) If I have a sell order in as GTC - if it hits that price after hours will the sell of mine go through?
3.) What is after hours trading? What hours? Weekends?
Up ticking!!! Let's close with a strong EOD run and KABOOOM on Monday.
WEEEEEEEEEEEEEEEEEEE
Oct 30, 2007 10:48:00 (ET)
NEW YORK and MONTREAL, Oct 30, 2007 /PRNewswire-FirstCall via COMTEX/ -- ICBS Limited (PINKSHEETS: ICBM), today announced the acquisition of 30% interest in Bacteria Bank Ltd.
Bacteria Bank Ltd., is a Bio medical company that owns over ten thousand cryogenically stored bacteria for use in medical research, located in Montreal Canada. The company is headed by Dr. Karl Weiss a world renowned bacteriologist.
Dr. Karl Weiss is a Microbiologist and Infectious Diseases Specialist at Maisonneuve-Rosemont Hospital in Montreal . He is also Associate Clinical Professor at the Faculty of Medicine at University of Montreal , and the director of pharmacological research at Maisonneuve-Rosemont hospital. He is also an associate member of the division of infectious diseases at the Jewish General Hospital in Montreal , and an adjunct-professor of Medicine at McGill University.
Bacteria bank has a unique collection of over 10,000 frozen bacteria which can be used for many different purposes.
1. susceptibility testing of potentially promising anti-microbial
agents developed by biotech companies or researchers in
universities.
2. susceptibility testing of new antibiotics against specific and
emerging pathogens such as MRSA ( Methicillin resistant
Staphyloccocus aureus), VRE ( Vancomycin Resistant Enterococcus).
3. susceptibility testing against a wide array of Gram negative
agents ( E. coli, Salmonella, shigella, and other gastro-
intestinal pathogens responsible for million of deaths every year
in the world)
4. susceptibility testing of new agents against Streptococcus
pneumoniae responsible for the majority of sinusitis, otitis
media, pneumonia and some forms of bronchitis. In North America
only, there are over 300 million of antibiotic prescriptions in
the outpatients setting, and S.pneumonie is the number one target
overall by far.
5. bacteria useful for the development of newly designed genetically
derived products ( human and animal hormones, growth factors,
cytokines...)
6. bacteria useful for teaching purposes ( Pharmaceutical companies,
universities and medical schools)
Speaking from the corporate head office in Montreal, Garth McIntosh, President &CEO of ICBS said, " This acquisition will further strengthen our position in the Bio medical industry". ICBS also owns 100% of Canadian Bio Med Systems Ltd. McIntosh further stated " I want to thank all of our shareholders that have supported us in the past year, we are working very hard to make this a profitable year for all. Thank you all for your encouragement and support".
You can visit them at: www.bacteriabank.com
This news release includes statements that constitute forward-looking statements. Please be aware that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may vary materially from those in the forward-looking statements as a result of any number of factors, including the risk factors contained in the Company's disclosure documents.
SOURCE INTER CANADIAN BUSINESS SERVICE
Can I get a screen shot please?
This is holding strong!!!
.0015 Close !!!!!
This is awesome!!!
I beleive we can fly !!!
Selling more than ask? This must be good.
A $1.29 sell went through and ask was only $1.27
Wow - already another uptick pre-market... Up 11.76%
I would just like to see it back up to $1.39 is all.
Hopefully we will see tremendous growth today.
Do OTC or BB or Pinks trade in pre-market?
What does everyone think MCZ will hit today? $1.39 ?
This stock is awesome. It bounced back up EOD.
I appreciate this board and it's professors.
We shall soon be looking square in the face of one million dollars !!!!
What is FB ?
where this one gonna be soon?
What will this stock get to from .0002 it is currently at? Does anyone think .005 this month which on a $200 investment would make you $5,000 ?
When is this baby gonna get past $2.00 ?
This would be really, really sweet.
This is a great company!!!